Mutant molecules of interest in myeloproliferative neoplasms: introduction.
Tefferi
Ayalew
A
D000970:Antineoplastic Agents / Q000627:therapeutic use; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000145:classification / Q000188:drug therapy / Q000235:genetics* / Q000378:metabolism; D009154:Mutation; D009190:Myelodysplastic Syndromes / Q000145:classification / Q000188:drug therapy / Q000235:genetics* / Q000378:metabolism; D009196:Myeloproliferative Disorders / Q000145:classification / Q000188:drug therapy / Q000235:genetics* / Q000378:metabolism; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors / Q000235:genetics*; D014411:Neoplastic Stem Cells / Q000378:metabolism
D000970:Antineoplastic Agents; D009363:Neoplasm Proteins